These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15405)

  • 1. Partial correction of hypertension by angiotensin II blockade in a patient with phaeochromocytoma.
    van Hoogdalem P; Donker AJ; Brentjens JR; van der Hem GK; Oosterhuis JW
    Acta Med Scand; 1977; 201(4):395-9. PubMed ID: 15405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Saralasin in resistant hypertensive crisis (author's transl)].
    Röckel A; Heidland A
    Med Klin; 1979 Mar; 74(11):401-7. PubMed ID: 34782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma crisis induced by saralasin. Relation of angiotensin analogue to catecholamine release.
    Dunn FG; De Carvalho JG; Kem DC; Higgins JR; Frohlich ED
    N Engl J Med; 1976 Sep; 295(11):605-7. PubMed ID: 820996
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma.
    Röckel A; Heidland A; Appel E; Palm D
    N Engl J Med; 1977 Jan; 296(1):50-1. PubMed ID: 830274
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin blockade: its clinical significance.
    Streeten DH; Anderson GH; Dalakos TH
    Am J Med; 1976 May; 60(6):817-24. PubMed ID: 1020761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of saralasin on hypertension due to phaeochromocytoma.
    Donker AJ
    Lancet; 1984 Aug; 2(8398):355. PubMed ID: 6146900
    [No Abstract]   [Full Text] [Related]  

  • 8. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA; Weaver JM; Fink GD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various inhbitors of the renin-angiotensin system and their clinical use].
    Bar-Andziak E
    Pol Arch Med Wewn; 1979 Jan; 61(1):69-74. PubMed ID: 370806
    [No Abstract]   [Full Text] [Related]  

  • 10. Drinking behavior in water deprived rats after angiotensin receptor blockade.
    Severs WB; Kapsha JM; Klase PA; Keil LC
    Pharmacology; 1977; 15(3):254-8. PubMed ID: 194267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blockade of brain angiotensin II receptors in conscious, sodium-deprived dogs.
    Brooks VL; Reid IA
    Am J Physiol; 1983 Dec; 245(6):R881-7. PubMed ID: 6318577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA; Mitchell HC
    Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immediate pressor effect of saralasin in man.
    Carey RM; Vaughan ED; Ackerly JA; Peach MJ; Ayers CR
    J Clin Endocrinol Metab; 1978 Jan; 46(1):36-43. PubMed ID: 752023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
    Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats.
    de Jonge A; Knape JT; van Meel JC; Kalkman HO; Wilffert B; Thoolen MJ; Timmermanns PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):309-13. PubMed ID: 6188064
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.